Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Biocytogen will provide proprietary, fully human antibodies derived from its RenMice platform for evaluation in Merck’s antibody-conjugated LNP services
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
The accelerated approval is supported by results from part 1 of the ESSENCE trial
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Subscribe To Our Newsletter & Stay Updated
